Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project

Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project

Background and objective: Papillary renal cell carcinoma (pRCC) is a rare disease. The optimal treatment of metastatic pRCC is still unclear. We evaluated real-world treatment outcomes of first-line treatment in this cohort in Germany. Methods: Patients with advanced or metastatic pRCC were eligible...

Full description

Saved in:
Bibliographic Details
Main Authors: Thomas Hilser, Jozefina Casuscelli, Can Aydogdu, Stefanie Zschäbitz, Marco Julius Schnabel, Emily Rinderknecht, Angelika Mattigk, Martin Schostak, Anna-Lisa Volk, Philipp Ivanyi, Jonas Wiegmann, Christopher Darr, Luka Flegar, Subhajit Mandal, Katrin Schlack, Daniel Seidl, Analena Handke, Melanie Klee, Tim Nestler, Marc Rehlinghaus, Sameh Hijazi, Axel Heidenreich, Viktor Grünwald, Pia Paffenholz
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:European Urology Open Science
Subjects:
Papillary renal cell cancer
Immune checkpoint inhibitor
Tyrosine kinase inhibitor
First-line treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168325002447
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items